Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Agios Pharma shares dive after anemia treatment development halted
Agios Pharma shares dive after anemia treatment development halted
Agios Pharma shares dive after anemia treatment development halted
Submitted by
admin
on December 15, 2016 - 6:45pm
Source:
Marketwatch
News Tags:
Agios Pharmaceuticals
clinical trials
AG-519
pyruvate kinase deficiency
Headline:
Agios Pharma shares dive after anemia treatment development halted
Do Not Allow Advertisers to Use My Personal information
